None listed
Conditions
Brief summary
This project aims to assist culturally and linguistically diverse consumers safely manage their complex medication regimens for the co-existing comorbidities of cardiovascular disease (CVD), diabetes and chronic kidney disease (CKD). Taking medicines as prescribed is critical for well-managed chronic diseases. Approximately 40% of Victorians with CVD, diabetes and CKD speak a language other than English at home, most commonly Greek, Italian, and Vietnamese, which increases the likelihood of medicine-related problems. A language-specific medication intervention to enhance medication self-efficacy will be developed and tested. Better medicine self-efficacy results in improved general wellbeing, medication safety and reduced healthcare costs. Null hypothesis: 1. Compared to patients receiving standard care, patients who receive the intervention will show no change in medication self-efficacy
Interventions
A subtitled DVD will be shown to the patient during the home visit conducted by the researcher in the presence of an interpreter or English-speaking family member.
The DVD will contain health information for consumers regarding medicines in relation to their chronic conditions to enhance decision-making and behavioural change.
A medication review will be conducted during the home visit by the researcher which involves checking the medication regimen with the patient to reach agreement about the
A subtitled DVD will be shown to the patient during the home visit conducted by the researcher in the presence of an interpreter or English-speaking family member. The DVD will contain health information for consumers regarding medicines in relation to their chronic conditions to enhance decision-making and behavioural change. A medication review will be conducted during the home visit by the researcher which involves checking the medication regimen with the patient to reach agreement about their treatment. Fortnightly 5-10 minute follow-up telephone calls will be made by an interpreter in liaison with the researcher or researcher with a family member who can interpret for the patient for a period of 12 weeks exploring any queries or problems relating to their medications. The intervention will last for 12 weeks.
Sponsors
The University of Melbourne
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Victorians whose preference is to speak either Greek, Italian or Vietnamese at home Diabetes, kidney disease and cardiovascular disease Mentally competent
Exclusion criteria
Pregnancy Imminent end stage kidney disease Aggressive form of cancer Mental illness not stabilised with medication.
Outcome results
None listed